Cell Reports (Sep 2020)
Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study
- Caroline Passaes,
- Antoine Millet,
- Vincent Madelain,
- Valérie Monceaux,
- Annie David,
- Pierre Versmisse,
- Naya Sylla,
- Emma Gostick,
- Sian Llewellyn-Lacey,
- David A. Price,
- Antoine Blancher,
- Nathalie Dereuddre-Bosquet,
- Delphine Desjardins,
- Gianfranco Pancino,
- Roger Le Grand,
- Olivier Lambotte,
- Michaela Müller-Trutwin,
- Christine Rouzioux,
- Jérémie Guedj,
- Véronique Avettand-Fenoel,
- Bruno Vaslin,
- Asier Sáez-Cirión
Affiliations
- Caroline Passaes
- Institut Pasteur, HIV Inflammation and Persistence, Paris, France; CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
- Antoine Millet
- Université Paris-Descartes, Sorbonne Paris Cité, Faculté de Médecine, EA 7327 Paris, France
- Vincent Madelain
- Université Paris-Diderot, IAME, INSERM UMR 1137, Sorbonne Paris Cité, Paris, France
- Valérie Monceaux
- Institut Pasteur, HIV Inflammation and Persistence, Paris, France
- Annie David
- Institut Pasteur, HIV Inflammation and Persistence, Paris, France
- Pierre Versmisse
- Institut Pasteur, HIV Inflammation and Persistence, Paris, France
- Naya Sylla
- CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
- Emma Gostick
- Cardiff University School of Medicine, Division of Infection and Immunity, Cardiff, UK
- Sian Llewellyn-Lacey
- Cardiff University School of Medicine, Division of Infection and Immunity, Cardiff, UK
- David A. Price
- Cardiff University School of Medicine, Division of Infection and Immunity, Cardiff, UK
- Antoine Blancher
- Université Paul Sabatier, Laboratoire d’Immunogénétique Moléculaire, EA 3034 Toulouse, France; CHU de Toulouse, Laboratoire d’Immunologie, Toulouse, France
- Nathalie Dereuddre-Bosquet
- CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
- Delphine Desjardins
- CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
- Gianfranco Pancino
- Institut Pasteur, HIV Inflammation and Persistence, Paris, France
- Roger Le Grand
- CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France
- Olivier Lambotte
- CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France; Assistance Publique-Hôpitaux de Paris, Service de Médecine Interne et Immunologie Clinique, Groupe Hospitalier Université Paris-Saclay, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
- Michaela Müller-Trutwin
- Institut Pasteur, HIV Inflammation and Persistence, Paris, France
- Christine Rouzioux
- Université Paris-Descartes, Sorbonne Paris Cité, Faculté de Médecine, EA 7327 Paris, France; Assistance Publique-Hôpitaux de Paris, Service de Microbiologie Clinique, Hôpital Necker-Enfants Malades, Paris, France
- Jérémie Guedj
- Université Paris-Diderot, IAME, INSERM UMR 1137, Sorbonne Paris Cité, Paris, France
- Véronique Avettand-Fenoel
- Université Paris-Descartes, Sorbonne Paris Cité, Faculté de Médecine, EA 7327 Paris, France; Assistance Publique-Hôpitaux de Paris, Service de Microbiologie Clinique, Hôpital Necker-Enfants Malades, Paris, France
- Bruno Vaslin
- CEA-Université Paris-Saclay, INSERM UMR1184, Center for Immunology of Viral, Auto-immune, Hematologic and Bacterial Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses, France; Corresponding author
- Asier Sáez-Cirión
- Institut Pasteur, HIV Inflammation and Persistence, Paris, France; Corresponding author
- Journal volume & issue
-
Vol. 32,
no. 12
p. 108174
Abstract
Summary: Highly efficient CD8+ T cells are associated with natural HIV control, but it has remained unclear how these cells are generated and maintained. We have used a macaque model of spontaneous SIVmac251 control to monitor the development of efficient CD8+ T cell responses. Our results show that SIV-specific CD8+ T cells emerge during primary infection in all animals. The ability of CD8+ T cells to suppress SIV is suboptimal in the acute phase but increases progressively in controller macaques before the establishment of sustained low-level viremia. Controller macaques develop optimal memory-like SIV-specific CD8+ T cells early after infection. In contrast, a persistently skewed differentiation phenotype characterizes memory SIV-specific CD8+ T cells in non-controller macaques. Accordingly, the phenotype of SIV-specific CD8+ T cells defined early after infection appears to favor the development of protective immunity in controllers, whereas SIV-specific CD8+ T cells in non-controllers fail to gain antiviral potency, feasibly as a consequence of early defects imprinted in the memory pool.